“Cost Management”

72 result(s)
Cost Management
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
An update on the gene therapy pipeline More
Briefing
Specialty
7 Stats That Show What Providers Think About Biosimilars
7 stats that show what providers think about biosimilars More
Briefing
Cost Management
The Dynamic PBM Landscape
The changing PBM landscape holds challenges for payors More
Commentary
Cost Management
Connected in Care: A Proactive Approach to Managing Specialty Drugs
Lowering specialty costs through ongoing engagement with members More
Briefing
Drug Pipeline
Managing New Drug Options for Obesity
... More
Briefing
2023 Forum
Drug Pipeline
The Dynamic Biosimilars Market
The Dynamic Biosimilars Market More
Video
A family dog-piles on a dad's back.
Drug Pipeline
Optimizing Treatment for Inflammatory Bowel Disease
New Drugs and Tools to Optimize IBD Treatment More
Briefing
Specialty
Member Education: How We Help Build Awareness
Supporting members through prescription changes with CVS Health’s many touchpoints, expertise, and data More
Briefing
Care Management
The Next Frontier for Obesity Treatment Is Here
New obesity medications are here highlighting the need for managing access and cost. More
Briefing
Drug Pipeline
Biosimilars in the Autoimmune Category
Biosimilars in the Autoimmune Category More
Briefing